141 related articles for article (PubMed ID: 38265787)
21. Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study.
Watts CG; Madronio C; Morton RL; Goumas C; Armstrong BK; Curtin A; Menzies SW; Mann GJ; Thompson JF; Cust AE
JAMA Dermatol; 2017 Jan; 153(1):23-29. PubMed ID: 27829101
[TBL] [Abstract][Full Text] [Related]
22. Metastatic acral lentiginous melanoma in a tertiary referral center in Switzerland: a systematic analysis.
Häfliger EM; Ramelyte E; Mangana J; Kunz M; Kazakov DV; Dummer R; Cheng PF
Melanoma Res; 2018 Oct; 28(5):442-450. PubMed ID: 29847461
[TBL] [Abstract][Full Text] [Related]
23. Treatment and outcomes of melanoma in acral location in Korean patients.
Roh MR; Kim J; Chung KY
Yonsei Med J; 2010 Jul; 51(4):562-8. PubMed ID: 20499423
[TBL] [Abstract][Full Text] [Related]
24. Distinctive features of melanoma and its management in elderly patients: a population-based study in France.
Ciocan D; Barbe C; Aubin F; Granel-Brocard F; Lipsker D; Velten M; Dalac S; Truchetet F; Michel C; Mitschler A; Arnoult G; Buemi A; Dalle S; Bernard P; Woronoff AS; Grange F
JAMA Dermatol; 2013 Oct; 149(10):1150-7. PubMed ID: 23945633
[TBL] [Abstract][Full Text] [Related]
25. Updated statistical data for malignant melanoma in Japan.
Ishihara K; Saida T; Yamamoto A;
Int J Clin Oncol; 2001 Jun; 6(3):109-16. PubMed ID: 11706778
[TBL] [Abstract][Full Text] [Related]
26. Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility.
Nagore E; Pereda C; Botella-Estrada R; Requena C; Guillén C
Cancer Causes Control; 2009 Feb; 20(1):115-9. PubMed ID: 18758972
[TBL] [Abstract][Full Text] [Related]
27. Early detection of acral melanoma: A review of clinical, dermoscopic, histopathologic, and molecular characteristics.
Darmawan CC; Jo G; Montenegro SE; Kwak Y; Cheol L; Cho KH; Mun JH
J Am Acad Dermatol; 2019 Sep; 81(3):805-812. PubMed ID: 30731177
[TBL] [Abstract][Full Text] [Related]
28. Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma.
Klemen ND; Wang M; Rubinstein JC; Olino K; Clune J; Ariyan S; Cha C; Weiss SA; Kluger HM; Sznol M
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32209601
[TBL] [Abstract][Full Text] [Related]
29. Risk Factors Associated With First and Second Primary Melanomas in a High-Incidence Population.
Olsen CM; Pandeya N; Dusingize JC; Neale RE; MacGregor S; Law MH; Whiteman DC;
JAMA Dermatol; 2023 Jan; 159(1):37-46. PubMed ID: 36416830
[TBL] [Abstract][Full Text] [Related]
30. Is the survival rate for acral melanoma actually worse than other cutaneous melanomas?
Lim Y; Lee J; Lee DY
J Dermatol; 2020 Mar; 47(3):251-256. PubMed ID: 31889335
[TBL] [Abstract][Full Text] [Related]
31. Genetic characteristics and response to systemic therapies of acral lentiginous melanoma at a tertiary care center-a retrospective review.
Jamerson T; Rebecca VW; Aguh C
J Natl Med Assoc; 2022 Feb; 114(1):7-11. PubMed ID: 34509302
[TBL] [Abstract][Full Text] [Related]
32. [Epidemiology and prognostic factors in cutaneous malignant melanoma].
Milo Y; Tamir G; Robinpour M; Sulkes J; Rotem A; Schachter J; Hauben DJ
Harefuah; 1995 Jun; 128(12):745-51, 824. PubMed ID: 7557679
[TBL] [Abstract][Full Text] [Related]
33. Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis.
Kolla AM; Vitiello GA; Friedman EB; Sun J; Potdar A; Daou H; Farrow NE; Farley CR; Vetto JT; Han D; Tariq M; Beasley GM; Contreras CM; Lowe M; Zager JS; Osman I; Berman RS; Liebman TN; Stein JA; Lee AY
Cancer Control; 2021; 28():10732748211053567. PubMed ID: 34752172
[TBL] [Abstract][Full Text] [Related]
34. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients.
Kuchelmeister C; Schaumburg-Lever G; Garbe C
Br J Dermatol; 2000 Aug; 143(2):275-80. PubMed ID: 10951133
[TBL] [Abstract][Full Text] [Related]
35. Risk of Mortality After a Diagnosis of Melanoma In Situ.
Patel VR; Roberson ML; Pignone MP; Adamson AS
JAMA Dermatol; 2023 Jul; 159(7):703-710. PubMed ID: 37285145
[TBL] [Abstract][Full Text] [Related]
36. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.
Jung JM; Jung CJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):498-508. PubMed ID: 33871216
[TBL] [Abstract][Full Text] [Related]
37. Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.
Ghiasvand R; Robsahm TE; Green AC; Rueegg CS; Weiderpass E; Lund E; Veierød MB
JAMA Dermatol; 2019 Jan; 155(1):39-49. PubMed ID: 30477003
[TBL] [Abstract][Full Text] [Related]
38. Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance.
Guitera P; Menzies SW; Coates E; Azzi A; Fernandez-Penas P; Lilleyman A; Badcock C; Schmid H; Watts CG; Collgros H; Liu R; van Kemenade C; Mann GJ; Cust AE
JAMA Dermatol; 2021 May; 157(5):521-530. PubMed ID: 33729464
[TBL] [Abstract][Full Text] [Related]
39. Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma.
Cheraghlou S; Ugwu N; Girardi M
JAMA Dermatol; 2022 Jan; 158(1):51-58. PubMed ID: 34878492
[TBL] [Abstract][Full Text] [Related]
40. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
